Cargando…
Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagy
Liver fibrosis is a dynamic reversible pathological process in the development of chronic liver disease to cirrhosis. However, the current treatments are not administered for a long term due to their various side effects. Autophagy is initiated to decompose damaged or excess organelles, which had be...
Autores principales: | Li, Jingjing, Chen, Kan, Li, Sainan, Feng, Jiao, Liu, Tong, Wang, Fan, Zhang, Rong, Xu, Shizan, Zhou, Yuqing, Zhou, Shunfeng, Xia, Yujing, Lu, Jie, Zhou, Yingqun, Guo, Chuanyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4758785/ https://www.ncbi.nlm.nih.gov/pubmed/26929597 http://dx.doi.org/10.2147/DDDT.S98740 |
Ejemplares similares
-
Pretreatment with Fucoidan from Fucus vesiculosus Protected against ConA-Induced Acute Liver Injury by Inhibiting Both Intrinsic and Extrinsic Apoptosis
por: Li, Jingjing, et al.
Publicado: (2016) -
Fucoidan from Fucus vesiculosus Inhibits Inflammatory Response, Both In Vitro and In Vivo
por: Wang, Lingzhi, et al.
Publicado: (2023) -
Biological effects of fucoidan isolated from Fucus vesiculosus on thrombosis and vascular cells
por: Kwak, Kyu-Won, et al.
Publicado: (2010) -
Commercial Fucoidans from Fucus vesiculosus Can Be Grouped into Antiadipogenic and Adipogenic Agents
por: Oliveira, Ruth Medeiros, et al.
Publicado: (2018) -
Quercetin prevents hepatic fibrosis by inhibiting hepatic stellate cell activation and reducing autophagy via the TGF-β1/Smads and PI3K/Akt pathways
por: Wu, Liwei, et al.
Publicado: (2017)